Abu Dhabi’s Burjeel to launch specialised lab for molecular genetics profiling to deal with most cancers

A sophisticated diagnostic lab will provide molecular genetics and immunological profiling exams to help oncologists and physicians within the analysis, threat stratification, and tailor-made therapy for sufferers with most cancers, genetic illnesses, or immune problems.

A second entity will broaden on Burjeel’s present analysis program and analyze most cancers sufferers’ genomic and immune signatures.

As a part of tutorial roles on the College of Calgary, OncoHelix’s scientists and clinicians have been concerned in translational analysis with over 350 publications in main scientific journals. They’ve developed ‘impactful precision oncology and immunology pipelines’ geared toward bettering scientific outcomes for most cancers sufferers and transplant recipients.

Burjeel Holdings is likely one of the largest healthcare providers suppliers within the MENA area with a community of 61 belongings, together with 16 hospitals and 23 medical facilities, in addition to pharmacies. Its Laboratory Companies arm – coLAB – operates a community of 12 laboratories, together with 4 accredited by the Faculty of American Pathologists.

OncoHelix has the best variety of clinically validated complete genomic profiling (CGP) panels for most cancers in Canada.